AR-67 - Moligand™ , DNA topoisomerase I inhibitor, CAS No.220913-32-6, DNA topoisomerase I inhibitor

CAS: 220913-32-6 Cat. No.: A607706 Formula: C26H30N2O5Si Molecular Weight: 478.6 PubChem CID: 6712744
AVAILABLE TO ORDER
GRADE & PURITY Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools.
Synonyms
Silatecan|(20S)-7-TERT-BUTYLDIMETHYSILYL-10-HYDROXYCAMPTOTHECIN|DB-67|(S)-11-(tert-Butyldimethylsilyl)-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione|AR67|AR-67|AR 67|1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 11-((1,1-dimethylethyl)dimethylsilyl)-4-ethyl-4,9-dihydroxy-, (4S)-|(19S)-10-[tert-butyl(dimethyl)silyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione|(20S)-7-t-Butyldimethylsilyl-10-hydroxycamptothecin|DB 67|AR-67 cpd|AR 67 cpd|1H-Pyrano[3',7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione, 11-[(1,1-dimethylethyl)dimethylsilyl]-4-ethyl-4,9-dihydroxy-, (4S)-|DB 67; Silatecan|DB67
Storage
Room temperature
★
Size
USA
Germany (EU)*
Price
Qty
5mg
A607706-5mg
Made to order · 8–12 wks

$1,142.90

$1,334.90
Save $192.00 (14.38%)
25mg
A607706-25mg
Made to order · 8–12 wks

$1,714.90

$2,000.90
Save $286.00 (14.29%)
Enter a quantity for the sizes you want to add.

Specifications

Synonyms
Silatecan | (20S)-7-TERT-BUTYLDIMETHYSILYL-10-HYDROXYCAMPTOTHECIN | DB-67 | (S)-11-(tert-Butyldimethylsilyl)-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione | AR67 | AR-67 | AR 67 | 1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 11-((1,1-dimethylethyl)dimethylsilyl)-4-ethyl-4,9-d Show more
Specifications & Purity
Moligand™
Storage
Room temperature
Grade
Moligand™
Action Type
INHIBITOR
Mechanism of action
DNA topoisomerase I inhibitor
Names and Identifiers
SMILES
CC[C@@]1(O)C(=O)OCc2c1cc1c3nc4ccc(cc4c(c3Cn1c2=O)[Si](C(C)(C)C)(C)C)O
IUPAC Name
(19S)-10-[tert-butyl(dimethyl)silyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
InChIKey
XUSKJHCMMWAAHV-SANMLTNESA-N
InChI
1S/C26H30N2O5Si/c1-7-26(32)18-11-20-21-16(12-28(20)23(30)17(18)13-33-24(26)31)22(34(5,6)25(2,3)4)15-10-14(29)8-9-19(15)27-21/h8-11,29,32H,7,12-13H2,1-6H3/t26-/m0/s1
Isomeric SMILES
CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C5=C(C=CC(=C5)O)N=C4C3=C2)[Si](C)(C)C(C)(C)C)O
PubChem CID
6712744
Molecular Weight
478.6

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassAlkaloids and derivatives
ClassCamptothecins
SubclassNot available
Intermediate Tree Nodes Not available
Direct ParentCamptothecins
Alternative Parents Hydroxyquinolines  Pyranopyridines  Pyridinones  1-hydroxy-2-unsubstituted benzenoids  Alkylarylsilanes  Tertiary alcohols  Heteroaromatic compounds  Lactones  Lactams  Carboxylic acid esters  Oxacyclic compounds  Organic metalloid salts  Monocarboxylic acids and derivatives  Azacyclic compounds  Carbonyl compounds  Hydrocarbon derivatives  Alkylsilanes  Organic oxides  Organonitrogen compounds  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Camptothecin - Hydroxyquinoline - Pyranopyridine - Quinoline - 1-hydroxy-2-unsubstituted benzenoid - Phenol - Pyridinone - Alkylarylsilane - Pyridine - Benzenoid - Heteroaromatic compound - Tertiary alcohol - Carboxylic acid ester - Lactam - Lactone - Organoheterocyclic compound - Carboxylic acid derivative - Monocarboxylic acid or derivatives - Oxacycle - Azacycle - Organic metalloid salt - Organonitrogen compound - Organic metalloid moeity - Organosilicon compound - Organic nitrogen compound - Organic oxygen compound - Organooxygen compound - Organic oxide - Hydrocarbon derivative - Carbonyl group - Alkylsilane - Alcohol - Aromatic heteropolycyclic compound
DescriptionThis compound belongs to the class of organic compounds known as camptothecins. These are heterocyclic compounds comprising a planar pentacyclic ring structure, that includes a pyrrolo[3,4-beta]-quinoline moiety (rings A, B and C), conjugated pyridone moiety (ring D) and one chiral center at position 20 within the alpha-hydroxy lactone ring with (S) configuration (the E-ring).
External Descriptors Not available
3D Structure
Interactive Chemical Structure Model





Associated Targets(Human)
Homo sapiens (32628 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A498 (42825 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHN (49357 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAKI-1 (44928 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
COLO 205 (50209 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KM12 (47707 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
M14 (47487 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MOLT-4 (49676 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-3 (48710 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-4 (44535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-5 (45555 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-8 (47708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RPMI-8226 (44974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RXF 393 (41971 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SF-295 (48000 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-2 (46422 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-28 (48833 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-5 (47095 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-OV-3 (52876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SN12C (47755 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SNB-19 (46794 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TK-10 (45540 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-251 (51189 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-87 MG (3946 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UACC-257 (46019 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UACC-62 (47335 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UO-31 (46270 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
786-0 (47912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI/ADR-RES (33767 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
T47D (39041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EKVX (44102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H322M (45589 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCC 2998 (41480 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HOP-92 (41141 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hs-578T (29457 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Tumor Cell line (551 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SF-268 (49410 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IGROV-1 (47897 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LOX IMVI (44321 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HOP-62 (47048 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mechanisms of Action
Certificates (CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Chemical and Physical Properties
Molecular Weight478.600 g/mol
XLogP3
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count6
Rotatable Bond Count3
Exact Mass478.192 Da
Monoisotopic Mass478.192 Da
Topological Polar Surface Area100.000 Ų
Heavy Atom Count34
Formal Charge0
Complexity982.000
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Solution Calculators
Reviews

Customer Reviews

Application Protocols

No tested/validated application protocols, assay conditions, or recommended dilutions are provided in the Product Data for this SKU. Please consult the peer-reviewed literature for protocol development appropriate to your assay type (biochemical, biophysical, or cell-based) and validate locally.

Protocol development tips (general guidance, not item-specific performance claims):

  • Prepare a concentrated DMSO stock and perform serial dilutions in DMSO to reach near-final concentrations before spiking into buffer/media.
  • Keep final DMSO content within the tolerance of your assay system (commonly ≤0.1–1% v/v in biochemical assays).
  • Include vehicle controls matched to the highest DMSO concentration used.
  • Confirm compound stability under assay conditions by orthogonal analytics (e.g., HPLC) when data interpretation depends on the lactone form.

If you require a starting point, search the literature by CAS (220913-32-6) or PubChem CID (6712744) together with your assay class (e.g., “Top1 cleavage assay,” “DNA relaxation assay,” or “stability in buffer”). Validate all conditions with small-scale pilots before routine use.

Biological Roles

The following summarizes literature knowledge about the biological role of camptothecin-class molecules and is provided for research context only. It does not constitute an item-specific performance claim and must not be interpreted as clinical guidance.

  • Molecular target (literature): DNA topoisomerase I. Camptothecin analogs intercalate at the Top1/DNA cleavage site, stabilizing the covalent Top1–DNA complex and preventing religation. This creates DNA single-strand breaks that can convert to double-strand breaks during replication.
  • Structural dependence: biological activity is highly sensitive to stereochemistry of the E-ring and integrity of the lactone. Hydrophobic substitutions (e.g., silyl substituents reported for AR-67) can shift the lactone–carboxylate equilibrium toward the active lactone in lipophilic environments.
  • Cellular pathways engaged: replication stress, S-phase checkpoint activation, and DNA damage response signaling cascades (e.g., ATM/ATR pathways; formation of γH2AX foci) in experimental systems.
  • Physicochemical determinants: lipophilicity and protein binding modulate distribution in model systems; pH and buffer composition influence lactone stability and thus observed potency in vitro.
  • Selectivity considerations: Top1 poisoning is enzyme- and DNA-context dependent; sequence preference around the cleavage site and chromatin state affect trapping efficiency (literature observations).

Research use boundaries: Use AR-67 strictly for in vitro/in vivo laboratory research with appropriate approvals. No medical, diagnostic, or clinical uses are intended or permitted for this catalog item.

Buffer Applications

AR-67 is not a buffering reagent. However, its behavior in buffers is important for experimental design. Guidance below is general/literature-based and not item-specific.

  • pH sensitivity: camptothecin-class lactones hydrolyze in basic aqueous media to the corresponding carboxylate, which is typically less active in Top1 assays. Maintain near-neutral pH (≈6.5–7.4) during working solution preparation; avoid pH > 8.
  • Working solution preparation:
    • Prepare concentrated DMSO stock (e.g., 10–50 mM; optimize to solubility) and dilute into the target buffer with vigorous mixing to a final DMSO content usually ≤0.1–1% v/v.
    • Add stock to buffer last, dropwise, to mitigate precipitation. If needed, include a small co-solvent fraction (e.g., DMSO:PEG400:buffer) or use cyclodextrin to enhance apparent solubility.
  • Common assay buffers: Tris, HEPES, or phosphate-buffered saline are frequently used for enzyme assays and cell-based media supplements. Note that Tris at elevated pH can accelerate lactone opening; HEPES near pH 7.4 is often preferred for stability (literature observation).
  • Filtration: Use low-binding 0.22 μm PTFE or PVDF filters to remove particulates; test for nonspecific adsorption.

No validated buffer recipes or stability specifications are provided for this SKU; consult the primary literature and perform pilot stability checks by HPLC to verify the lactone/carboxylate ratio under your exact conditions.

Green Alternatives

As AR-67 is a discrete small molecule used for screening and mechanistic studies rather than a consumable solvent or bulk reagent, “green alternative” considerations focus on solvent systems and handling practices rather than replacement of the molecule itself.

Greener handling strategies (literature guidance):

  • Prefer high-boiling, low-VOC co-solvents when feasible: PEG 300/400 or aqueous cyclodextrin solutions can reduce reliance on chlorinated solvents in preparative steps and can aid solubilization for certain assays.
  • Minimize chlorinated solvent use (CH2Cl2/CHCl3) for sample prep; substitute with ethyl acetate, CPME, or Me-THF when compatible with the compound’s stability and the analytical method.
  • Use micro-scale assays: plate-based workflows with low dead volumes significantly reduce chemical footprint for potent bioactives.
  • Implement closed-transfer stock handling (septum vials, positive displacement) to limit exposure and waste.

Illustrative comparison for solution preparation (general):

  • DMSO stocks (conventional): excellent solubilization; moderate environmental burden; widely accepted in bioassays.
  • DMSO + PEG400/buffer (greener blend): can decrease the required DMSO fraction in working solutions; viscosity may complicate pipetting—validate dispensing.
  • Cyclodextrin inclusion complexes: enable aqueous handling at lower organic content; require characterization to ensure consistent free concentration.

Disposal: Collect all unused solutions and contaminated disposables as hazardous waste; avoid drain disposal. Evaluate solvent recycling programs for DMSO and alcohol blends where available.

Pharmaceutical Uses

This catalog item is supplied strictly for research use only. No medical, diagnostic, or clinical applications are supported or permitted.

Research/formulation context (general, not item-specific claims):

  • Reference standard for analytical methods: AR-67 can serve as a research reference material during preformulation studies to develop and qualify HPLC methods that distinguish lactone and carboxylate forms, assess degradation products, and establish mass balance.
  • Excipient compatibility screening: In non-clinical formulation research, investigators often screen solvent/co-solvent systems (DMSO, ethanol, PEGs), cyclodextrins, and surfactants (e.g., polysorbates) for solubilization and stability—data are assay-development aids only.
  • Forced-degradation studies: Useful for mapping pH/oxidative/light stress pathways to inform stabilization strategies in research settings.

Regulatory notes:

  • Pharmacopeial status: Not specified for this item; refer to CoA/Spec Sheet.
  • Residual solvent, elemental impurities, and microbial limits: Not specified for this item; refer to CoA/Spec Sheet.

Any exploration of dosage forms, toxicology, or ADME must remain within the boundaries of non-clinical laboratory investigation and institutional approvals. For any application beyond bench research, procure GMP-grade materials and follow applicable regulations; this SKU is not intended for such uses.

Physical Properties

Item-specific physical constants were not provided in the catalog entry. Where available, consult the CoA/Spec Sheet for definitive values.

Item-specific (from Product Data):

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Storage Conditions: Room temperature (per Product Data).

General/literature characteristics for AR-67/camptothecin-class silylated analogs (for context only; not item specifications):

  • Physical state: typically a yellow to yellow-orange solid in purified form.
  • Solubility profile: highly soluble in polar aprotic organic solvents (DMSO; DMF) and moderately soluble in chlorinated organics (e.g., dichloromethane, chloroform); sparingly soluble in alcohols; very low intrinsic aqueous solubility at neutral pH unless aided by co-solvents, complexants (e.g., cyclodextrins), or surfactants.
  • Partitioning: increased lipophilicity relative to parent camptothecin, favoring the closed lactone in nonpolar media (literature observation).
  • Thermal behavior: complex polycyclic systems often show broad or decomposition-initiated melting; handle with minimal thermal stress (literature caution). Specific melting point for this item is not provided.
  • Spectral characteristics: UV-active polyaromatic system with strong absorbance in the near-UV; specific λmax and extinction coefficients vary by substitution and solvent (literature note).

Do not treat the above literature points as specifications for this SKU. For quantitative data (mp, solubility limits, UV cutoffs, purity assays), refer exclusively to the item’s CoA/Spec Sheet and SDS.

Quality & Grades
  • Grade/Purity: Moligand™ (per Product Data)

What Moligand grade typically implies (general description; consult CoA for item-specific specifications):

  • Intended use: discovery chemistry and screening collections (small-molecule libraries), suitable for in vitro research, HTS, and mechanism-of-action studies where reliable identity and purity are essential.
  • Quality controls commonly associated with screening-grade small molecules: structure confirmation (e.g., 1H NMR/MS), purity by HPLC/UPLC with UV detection, and controlled residual solvents. Exact test methods and acceptance criteria vary by catalog and lot; defer to the item’s CoA.
  • Stabilizers/additives: Not specified for this item; refer to CoA/Spec Sheet. Unless stated, assume neat compound without excipients.
  • UV background considerations: For assay readouts using UV/fluorescence, screening-grade materials are typically assessed for purity; however, “HPLC grade solvent” criteria such as low UV cutoff do not apply to solids. Evaluate potential assay interference empirically.

What to check on receipt:

  • Identity and purity: verify against the provided CoA (HPLC purity, MS/NMR ID).
  • Water content/residual solvents/metals: Not specified for this item; refer to CoA/Spec Sheet.
  • Form and counter-ions: If supplied as free base/neutral molecule vs. salt/solvate can affect solubility; specific form is Not specified for this item.

Traceability:

  • Retain lot-specific CoA and SDS for your records and regulatory documentation (research use only).
Reaction & Applications

This product is offered as a research small molecule (screening/assay use), not primarily as a synthetic reagent. Accordingly, “reaction” use is generally out of scope. The following focuses on applications in discovery and mechanistic studies (literature-based, not item-specific performance claims):

Discovery and mechanism-of-action studies:

  • Enzyme biochemistry: camptothecin-class molecules are prototypical poisons of DNA topoisomerase I in biochemical systems, stabilizing the covalent cleavage complex. AR-67 is frequently employed as a lipophilic analog to interrogate lactone stability and hydrophobic partitioning effects.
  • Biophysical assays: used in DNA cleavage-complex trapping assays, fluorescence/UV binding studies (using DNA oligos and purified Top1), and kinetic measurements of cleavage/religation in the presence of inhibitors.
  • Chemical biology: probe in cell-free or cellular systems to modulate DNA processing pathways, enabling mapping of DNA damage response markers (e.g., γH2AX) and checkpoint activation. Ensure work remains within non-clinical research scope.

Analytical applications:

  • Reference standard: serves as a comparator compound for LC/UV method development aimed at resolving lactone vs carboxylate forms and profiling stability in various matrices.
  • Partitioning/stability evaluations: suitable in partition studies (octanol/buffer) and pH-dependent interconversion experiments to understand lactone opening kinetics (monitored by HPLC).

Note: If you intend to use AR-67 in chemical synthesis (e.g., derivatization studies), consult the primary literature for protecting-group compatibility and avoid basic conditions that compromise the E-ring lactone.

Reaction Conditions

This section provides practical preparation/handling conditions relevant to AR-67 as a research compound rather than synthetic reaction recipes. All points are general/literature-based and should be validated in your lab.

Stock solution preparation:

  • Solvent: DMSO is preferred for concentrated stocks. DMF or NMP are alternatives for non-biological workflows.
  • Concentration: prepare 10–50 mM stocks depending on solubility; warm gently (≤40 °C) and vortex/sonicate to assist dissolution. Avoid prolonged heating.
  • Light and air: minimize strong light exposure during solution prep; cap tightly to limit hydrolysis.

Working solutions:

  • Dilution: add DMSO stock to buffered media with vigorous mixing; final DMSO typically ≤0.1–1% v/v for biochemical assays. Maintain pH 6.5–7.4 to favor lactone stability.
  • Compatibility: avoid strong bases, primary amines, and nucleophiles that can open the lactone. Maintain low-binding plastics or glass to reduce adsorption losses; verify recovery.

Stability monitoring:

  • Analytical: use HPLC (reverse-phase) to monitor lactone vs carboxylate forms over time; validate sample handling (immediate quench, temperature control) to avoid artifactual conversion.
  • Temperature: store working solutions at 2–8 °C for short durations as needed; return to room temperature before use and avoid repeated warm/cool cycles.

If pursuing chemical transformations (not typical for this SKU):

  • Protect the lactone from base; employ neutral/acidic, anhydrous conditions.
  • General reactivity of silyl groups follows standard TBS behavior (fluoride/acids cleave). Validate on micro-scale before scale-up.
Safety & Handling

Authoritative safety information resides in the product SDS; consult it before use. The catalog entry does not list GHS details for this item.

Item-specific (from Product Data):

  • GHS Classification: Not specified for this item; refer to SDS.
  • Signal Word / H-Statements / Pictograms: Not specified for this item; refer to SDS.
  • Storage Conditions: Room temperature.

General laboratory safety guidance for camptothecin-class research compounds (literature, not item-specific):

  • Hazard profile: Many camptothecin analogs are potent cytotoxic agents that interfere with DNA topology in proliferating cells. Handle as a highly active research compound. Avoid inhalation, ingestion, and skin contact. Use a chemical fume hood or designated containment for cytotoxics.
  • PPE: lab coat, double nitrile gloves when weighing/handling solids, safety glasses or face shield. Change outer gloves frequently; avoid contamination of common surfaces.
  • Engineering controls: handle powders in a ventilated balance enclosure when possible; use closed transfer for stock solutions.
  • Incompatibilities: strong bases and nucleophiles can promote lactone opening; strong oxidants may degrade the polycyclic core. Avoid prolonged exposure to basic aqueous media and strong light.
  • Spills and decontamination: absorb liquid spills with inert material; decontaminate with appropriate solvent, collect as hazardous waste. For solids, dampen to avoid dust, scoop carefully.
  • First aid (overview): rinse skin with water and soap upon contact; flush eyes with water for ≥15 min; if inhaled, move to fresh air; if ingested, seek medical attention. Bring SDS to healthcare provider.

Waste: Collect all solutions and contaminated disposables as hazardous chemical waste following institutional cytotoxic handling policies.

Solvent Selection

Guidance below is based on the common behavior of lipophilic camptothecin analogs and is provided for planning purposes. Verify solubility empirically for your lot.

Polarity and miscibility (general/literature):

  • Polarity class: moderately nonpolar, aromatic heterocycle with polar functionalities; overall behavior is lipophilic.
  • Preferred solvents for stock solutions: DMSO (most common), DMF, NMP; acceptable in chlorinated organics (CH2Cl2, CHCl3) for processing or analytics.
  • Poor solvents: water at neutral pH; basic aqueous buffers can hydrolyze the lactone and change solubility behavior.

Working solution strategies:

  • DMSO-based stocks (e.g., 10–50 mM) are typically prepared, then diluted into assay buffers to ≤0.1–1.0% v/v DMSO final (optimize for your biology). Use serial dilution in DMSO to maintain accuracy before buffer addition.
  • For enhanced aqueous delivery: consider cyclodextrin inclusion (e.g., 2‑HP‑β‑CD), co-solvent systems (DMSO/PEG400/buffer), or lipid-based carriers for biophysical assays.
  • Avoid prolonged exposure to basic media; maintain near-neutral pH during dilutions to preserve the lactone form where desired (literature consideration for camptothecins).

Comparison (literature tendencies):

  • DMSO vs DMF: DMSO offers greater biocompatibility in cell-free assays and easier handling; DMF may wet some plastics better but can be more cytotoxic.
  • Alcohols (EtOH/MeOH): limited solubility and potential for transesterification under strong conditions; use mainly for analytical sample prep if validated.

Always filter sterilize through PTFE or low-binding PVDF if sterile working solutions are required; confirm compound recovery to avoid adsorption losses.

Storage & Reconstitution

Item-specific storage and shipping:

  • Storage Conditions: Room temperature (per Product Data).
  • Shipped In: Not specified for this item; refer to CoA/Spec Sheet.

Reconstitution (general guidance; not item-specific specifications):

  • Solvent selection: use anhydrous DMSO to prepare concentrated stock solutions. Alternative solvents (DMF, NMP) may be used for non-biological applications after compatibility checks.
  • Target stock concentration: choose 10–50 mM based on solubility; sonication and gentle warming (≤40 °C) can aid dissolution. Do not boil or expose to strong light.
  • Aliquoting: dispense into amber, low-dead-volume vials; flush headspace with inert gas if long-term storage is anticipated to mitigate hydrolysis/oxidation.
  • Storage of solutions: freeze aliquots at −20 °C or below for extended storage if compatible with your workflow; avoid repeated freeze–thaw by using single-use aliquots. Note: these are general best practices; the Product Data only specifies room temperature for the solid.

Stability notes (literature):

  • Aqueous/basic conditions promote lactone opening; maintain neutral pH in working solutions.
  • Protect from strong light during handling to avoid potential photodegradation.

Always defer to the lot-specific CoA and SDS for definitive instructions on storage, reconstitution limits, and stability. Research Use Only.

Structure & Identity

Brief overview: AR-67 is a research small molecule in the Moligand screening library. In the open literature, AR-67 is widely described as a camptothecin-class scaffold bearing a silyl substitution that enhances lipophilicity and lactone stability. Item-specific structural identifiers provided below reflect the catalog listing; where not provided, consult the CoA/Spec Sheet.

  • SKU: A607706
  • Product Name: AR-67
  • CAS: 220913-32-6
  • PubChem CID: 6712744 (literature identifier)
  • InChIKey: 427815 (incomplete in product data)
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.

Structural features (literature description, not item-specific specs):

  • Core chemotype: camptothecin family pentacyclic framework containing a fused quinoline-type system and an E-ring lactone.
  • Functional groups: lactone (susceptible to hydrolysis to a carboxylate in basic media), phenolic/allylic hydroxyl (in many analogs), tertiary amide-like lactam within the pentacycle, and an aromatic hetero-fused ring system.
  • Substitution pattern: AR-67 is reported in literature to incorporate a trialkylsilyl substituent on the A-ring (e.g., tert-butyldimethylsilyl on C-7 in common depictions), increasing hydrophobicity and stabilizing the lactone form in hydrophobic environments.
  • Stereochemistry: camptothecin analogs possess multiple defined stereocenters in the fused ring system; configuration is critical to biological activity (literature note).

2D description in words (literature): a rigid, polycyclic, planar-heteroaromatic system fused to a δ-lactone, with a distal silyl-alkyl appendage and a constrained chiral tertiary lactam center.

Synthetic Utility

AR-67 is offered as a finished small molecule for screening and mechanistic studies, not as a building block. Nevertheless, camptothecin scaffolds present well-defined reactivity patterns (literature context) that may interest medicinal and synthetic chemists.

Key functional elements (literature):

  • E-ring lactone: susceptible to base-catalyzed opening to the carboxylate; conditions that conserve the closed lactone are typically mildly acidic to neutral and anhydrous or lipophilic.
  • Aromatic A/B-ring substitution: electrophilic aromatic substitutions are generally challenging on deactivated systems; directed metalation or cross-coupling strategies on prefunctionalized intermediates are preferred in synthesis.
  • Tertiary lactam and chiral centers: configuration is crucial; racemization is not typically an issue under mild conditions but can occur under harsh reagents.
  • Silyl substituent (as reported for AR-67): trialkylsilyl groups are normally robust under neutral conditions but can be cleaved by fluoride or strong acids (general TBS-chemistry behavior). Any derivatization should be validated experimentally due to the sensitive lactone.

Applications for method development:

  • Stability-indicating analytics: develop LC methods that resolve lactone/carboxylate forms and detect silyl deprotection products.
  • Late-stage functionalization (LSF) studies: explore selective oxidation, photochemistry, or mild cross-coupling on suitably prefunctionalized analogs to expand SAR space (requires bespoke pathways; not routine from AR-67 itself).

Because of its structural complexity and sensitivity, AR-67 is not generally used as a synthon in multistep synthesis; rather, it is a target or reference molecule in SAR campaigns.

Target Specificity

Only item-specific target information from the catalog may be listed here. For this SKU, no such information is provided.

  • Target/antigen name: Not specified for this item; refer to CoA/Spec Sheet.
  • Epitope/binding site: Not applicable.
  • Species reactivity/clone/isotype: Not applicable.

General literature note (not item-specific): camptothecin-class molecules are widely studied as poisons of DNA topoisomerase I in biochemical assays. This note is provided solely for research context; it is not a validated specification for this product.

Need help choosing the grade?

Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.

View Moligand™ grade guide →

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.